Differences occurred between the full-year consolidated earnings forecast for the 2026 July term and actual results. Net sales were higher than the previous forecast, actual result was 13,883 million yen vs. the previous forecast of 13,500 million yen. Operating income was 494 million yen, ordinary income was 602 million yen, and net income attributable to owners of parent was 364 million yen. Ordinary income benefited from foreign exchange gains. New lineups, advertising investments, and fixed-cost reductions were implemented as planned. A special loss was recognized due to dissolution of local subsidiaries.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4934","jir_company_name":"Premier Anti-Aging Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-09-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/09\/4934-20260914-03.pdf","jir_short_summary":"Differences occurred between the full-year consolidated earnings forecast for the 2026 July term and actual results. Net sales were higher than the previous forecast, actual result was 13,883 million yen vs. the previous forecast of 13,500 million yen. Operating income was 494 million yen, ordinary income was 602 million yen, and net income attributable to owners of parent was 364 million yen. Ordinary income benefited from foreign exchange gains. New lineups, advertising investments, and fixed-cost reductions were implemented as planned. A special loss was recognized due to dissolution of local subsidiaries.","jir_summary":"### Difference in Results\nThere was a difference between the full-year results forecast for the 2026 July term and actual results. Company-wide net sales reached the plan, but the aging-care segment\u2019s new customer acquisition recovery took longer, and mail-order sales fell below last year. On the other hand, the recovery market expansion supported sales mainly in offline channels. As a result of pursuing advertising and promotional investments and fixed-cost reductions, operating income exceeded the plan, and ordinary income rose due to foreign exchange gains. \n\n### Outlook and Structural Reform\nWe decided to consolidate the sales structure in the China market into cross-border EC and proceeded with dissolution and liquidation of the local subsidiary. Related business-structure reform costs were recognized as special losses. Going forward, we will continue promotional activities for new lines and cost management to improve profitability.","jir_financial_highlights":"Net Sales: 13,883 million yen (Compared to the previous disclosed forecast 13,500 million yen, +383 million yen)\nOperating Income: 494 million yen (Compared to the previous forecast 300 million yen, +194 million yen)\nOrdinary Income: 602 million yen (Compared to the previous forecast 300 million yen, +302 million yen)\nNet Income Attributable to Owners of Parent: 364 million yen (Compared to the previous forecast 300 million yen, +64 million yen)\nEarnings per Share: 41.77 yen (Compared to the previous disclosed forecast 34.40 yen, +7.37 yen)","jir_category":"","jir_hashtags":"#PremierAntiAgingInc.IR information does not have a specific theme","jir_key_figures":"Net Sales: 13,883 million yen\uff08Compared to previous forecast 13,500 million yen, +383 million yen\uff09\nOperating Income: 494 million yen\uff08Compared to previous forecast 300 million yen, +194 million yen\uff09\nNet Income Attributable to Owners of Parent: 364 million yen\uff08Compared to previous forecast 300 million yen, +64 million yen\uff09","jir_meta_title":"\u3010Premier Anti-Aging Inc.\u30112026 July Term Difference Report\uff5cNet Sales in Line with Plan, Net Income Upward","jir_meta_description":"Summary of differences between Premier Anti-Aging Inc.'s full-year 2026 July-term consolidated earnings forecast and actual results, including figures for sales and profits, reasons for differences, and future policy. Explains gains from foreign exchange and the China business restructuring.","jir_og_title":"Premier Anti-Aging Inc. | July Term Difference Report","jir_og_description":"Summary of the earnings difference report for the 2026 July term. Net sales in line with plan, operating and ordinary income above expectations, with special losses recorded for business restructuring. Explains future business structure reform and growth strategy.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59723,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-113810","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n